MARKET

RNA

RNA

Avidity Biosciences, Inc.
NASDAQ
72.14
-0.06
-0.08%
After Hours: 72.17 +0.03 +0.04% 16:24 12/23 EST
OPEN
72.06
PREV CLOSE
72.20
HIGH
72.19
LOW
72.05
VOLUME
1.15M
TURNOVER
--
52 WEEK HIGH
72.61
52 WEEK LOW
21.51
MARKET CAP
10.87B
P/E (TTM)
-17.3018
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RNA last week (1215-1219)?
Weekly Report · 1d ago
Avidity Biosciences downgraded to In Line from Outperform at Evercore ISI
TipRanks · 5d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Novan (NOVN), Avidity Biosciences (RNA) and Insmed (INSM)
TipRanks · 5d ago
Avidity reports FTC granted request for early termination of HSR waiting period
TipRanks · 5d ago
Avidity Biosciences Receives FTC Clearance for Novartis Merger
TipRanks · 5d ago
Avidity Biosciences Accelerates Executive Payouts Ahead of Novartis Merger
Reuters · 5d ago
LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF
Seeking Alpha · 6d ago
Top 2 Health Care Stocks That May Keep You Up At Night In December
Benzinga · 12/16 13:30
More
About RNA
Avidity Biosciences, Inc. is a biopharmaceutical company. The Company is engaged in delivering a new class of ribonucleic acid (RNA) therapeutics called antibody oligonucleotide conjugates (AOCs). The AOCs are designed to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to address targets and diseases previously unreachable with existing RNA therapies. Its advancing and expanding pipeline has three programs in clinical development. The Del-desiran is designed to treat people with myotonic dystrophy type 1 (DM1) and is in the global Phase III HARBOR trial and in the ongoing MARINA-OLE trial in people with DM1. The Delpacibart braxlosiran is the first investigational therapy designed to directly target DUX4 in people living with facioscapulohumeral muscular dystrophy (FSHD). The Del-zota is designed for people with Duchenne muscular dystrophy (DMD) and is in development with the Phase II EXPLORE44 open-label extension (OLE) study.

Webull offers Avidity Biosciences Inc stock information, including NASDAQ: RNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RNA stock methods without spending real money on the virtual paper trading platform.